These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2635317)

  • 1. [Potential cardiotonic agents. 4. Synthesis, cardiovascular activity, molecular and crystal structure of 5-phenyl- and 4-(4-pyridinyl)-substituted 2(1H)-pyridinethiones].
    Hagen V; Rumler A; Reck G; Hagen A; Labes D; Heer S
    Pharmazie; 1989 Dec; 44(12):809-13. PubMed ID: 2635317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Potential cardiotonic agents. 6. Synthesis and cardiovascular properties of 5-(4-pyridinyl)-, 6-methyl-5-(4-pyridinyl)- and 6-methyl-5-phenyl-substituted 3-cyano-2-oxaalkyoxy-pyridines].
    Hagen V; Klauschenz E; Rumler A; Hagen A; Heer S; Mitzner R; Niedrich H; Lohmann D
    Pharmazie; 1990 Mar; 45(3):189-90. PubMed ID: 2381960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Potential cardiotonic agents. 1. Synthesis and pharmacologic properties of 3-cyano-2-oxaalkylamino-5-(4-pyridinyl)pyridines].
    Hagen V; Hagen A; Heer S; Mitzner R; Niedrich H
    Pharmazie; 1989 Jan; 44(1):20-3. PubMed ID: 2727022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Potential cardiotonics. 14. Synthesis and in vitro positive inotropic actions of 4-morpholino-5-(4-pyridinyl)pyridine derivatives].
    Hagen V; Hagen A; Krause EG; Klauschenz E
    Pharmazie; 1992 Oct; 47(10):767-9. PubMed ID: 1480654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Potential cardiotonics. 7. Synthesis and cardiovascular effects of 5-(4-pyridinyl)-, 6-methyl-4-(4-pyridinyl) and 6-methyl-5-phenyl-substituted 3-cyano-2-aminoalkylamino-pyridines].
    Hagen V; Rumler A; Klauschenz E; Hagen A; Heer S; Faust G; Mitzner R
    Pharmazie; 1990 Apr; 45(4):240-1. PubMed ID: 2381972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Potential cardiotonic agents. 2. Synthesis and pharmacologic properties of 5-(pyri-4-yl)- and 5-phenyl substituted 3-cyano-6-methyl-2-oxaalkylaminopyridines].
    Klauschenz E; Rumler A; Hagen V; Hagen A; Heer S; Mitzner R; Niedrich H
    Pharmazie; 1989 Jan; 44(1):23-5. PubMed ID: 2727023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Potential cardiotonic agents. 10. Synthesis and positive inotropic action of 5-(4-pyridinyl)- and 5-phenyl-substituted 2-alkylthio-3-cyan-pyridines and their S-oxidation products].
    Rumler A; Hagen V; Hagen A
    Pharmazie; 1990 Sep; 45(9):657-9. PubMed ID: 2284307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Synthesis of 3-cyano-6-methyl-4-pyridyl-2(1H)-pyridinethiones as well as 2-substituted 6-methyl-4-pyridyl-pyridine-3-carbonitriles and 3-carbonic acid amides, respectively, and testing their cardiovascular activity].
    Hanfeld V; Leistner S; Wagner G; Lohmann D; Poppe H; Heer S
    Pharmazie; 1989 Jan; 44(1):12-5. PubMed ID: 2727021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Synthesis of 3-substituted 6-methyl-4-pyridyl-2 (1H) pyridones and testing of their cardiovascular action].
    Hanfeld V; Leistner S; Wagner G; Lohmann D; Poppe H; Heer S
    Pharmazie; 1988 Oct; 43(10):677-9. PubMed ID: 3212010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Potential cardiotonic agents. 8. 2-acyloxyalkylamino-, 2-acyloxyalkoxy-, and 2-acylaminoalkylamino-3-cyan-5-(pyrid-4-yl) pyridine].
    Hagen V; Klauschenz E; Rumler A; Niedrich H; Hagen A; Heer S; Mitzner R
    Pharmazie; 1990 May; 45(5):343-5. PubMed ID: 2395896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo cardiotonic activity of pyridylmethylene-2-indolinones.
    Andreani A; Locatelli A; Morigi R; Leoni A; Bossa R; Chiericozzi M; Galatulas I
    Arzneimittelforschung; 1998 Jul; 48(7):727-9. PubMed ID: 9706372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and cardiotonic activity of novel pyrimidine derivatives: crystallographic and quantum chemical studies.
    Dorigo P; Fraccarollo D; Santostasi G; Maragno I; Floreani M; Borea PA; Mosti L; Sansebastiano L; Fossa P; Orsini F; Benetollo F; Bombieri G
    J Med Chem; 1996 Sep; 39(19):3671-83. PubMed ID: 8809156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and cardiotonic activity of 2-substituted 5-cyano-1,6-dihydro-6-oxo-3-pyridinecarboxylic acids and their methyl or ethyl esters.
    Mosti L; Menozzi G; Schenone P; Dorigo P; Gaion RM; Belluco P
    Farmaco; 1992 Apr; 47(4):427-37. PubMed ID: 1388591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Potential cardiotonic agents. 11. Synthesis and cardiovascular effects of 5-alkyl-substituted 2-amino-3-cyano-5- -4-dyl)pyridines].
    Klauschenz E; Hagen V; Hagen A; Heer S
    Pharmazie; 1990 Jul; 45(8):628. PubMed ID: 2080215
    [No Abstract]   [Full Text] [Related]  

  • 15. [Potential cardiotonics. 13. Crystal structure, charge distribution and molecular electrostatic potential of 3-cyano-2-(3-diethyl-aminopropylamino)-5-(4-pyridinyl)pyridine (AWD 122-60)].
    Reck G; Hagen V; Labes D
    Pharmazie; 1992 Mar; 47(3):192-4. PubMed ID: 1615024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Potential cardiotonics. 16. Molecular and crystal structures of three polymorphic forms and a hydrochloride monohydrate of 3-cyano-2-morpholino-5-(pyridin-4-yl)pyridine (AWD 122-14)].
    Reck G; Hagen V; Bannier G
    Pharmazie; 1992 Nov; 47(11):852-6. PubMed ID: 1492114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and positive inotropic activity of several 5-aminopyrido[2,3-d]pyrimidines. Part 5: Compounds with positive inotropic activity.
    Heber D; Ravens U; Schulze T
    Pharmazie; 1993 Jul; 48(7):509-13. PubMed ID: 8415847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3,4-trans-4-Aryl-3-(1-pyridinio)-1,2,3,4-tetrahydropyridine-6-thiolates--new group of potential cardiotonic drugs.
    Krauze A; Vītoliņa R; Garaliene V; Sīle L; Klusa V; Duburs G
    Eur J Med Chem; 2005 Nov; 40(11):1163-7. PubMed ID: 15927309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationship studies of xanthone and fluorenone-1,4-dihydropyridine-5-phosphonates.
    Budriesi R; Rampa A; Bisi A; Fabbri G; Chiarini A; Valenti P
    Arzneimittelforschung; 1996 Apr; 46(4):374-7. PubMed ID: 8740081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Potential cardiotonics. 9. Synthesis and cardiovascular effects of 2-(pyrid-3-yl)-methylamino-, 2-(3-amino-pyrazolidino)- and 2-hetarylamino-substituted 3-cyan-5-(pyrid-4-yl)-pyridines].
    Roloff B; Schäfer J; Rumler A; Hagen V; Hagen A
    Pharmazie; 1989 Dec; 44(12):859-60. PubMed ID: 2635323
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.